Callahan P M, Cunningham K A
Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston 77550.
Eur J Pharmacol. 1990 Sep 4;186(1):143-7. doi: 10.1016/0014-2999(90)94072-6.
Calcium channel blockers appear to reduce the cardiac toxicity of cocaine and some stimulant-induced behaviors. The present experiment was designed to test whether the internal state induced by cocaine is altered by the calcium antagonist nimodipine. Substitution tests with the calcium agonist BAY K 8644 were also conducted in rats (N = 8) trained to discriminate cocaine (10 mg/kg) from saline in a two-lever, water-reinforced drug discrimination paradigm. Cocaine (0.625-10 mg/kg) produced a dose-related increase in drug-lever responding while BAY K 8644 (0.25-2 mg/kg) and nimodipine (0.2-0.8 mg/kg) engendered primarily saline responding. In combination with cocaine (2.5-10 mg/kg), nimodipine shifted the cocaine dose-response curve to the right at doses of 0.2 and 0.4 mg/kg; this attenuation did not increase with higher doses of nimodipine (0.8 and 1.6 mg/kg). The present results suggest that nimodipine may partially block the discriminative stimulus properties of cocaine, however, this reduction is neither robust nor dose-related. Thus, nimodipine might be expected to only marginally alter the subjective cocaine state in humans.
钙通道阻滞剂似乎能降低可卡因的心脏毒性以及一些由兴奋剂引起的行为。本实验旨在测试钙拮抗剂尼莫地平是否会改变可卡因诱导的内在状态。同时,在经过训练能在双杠杆、水强化药物辨别范式中区分可卡因(10毫克/千克)和生理盐水的大鼠(N = 8)中,也进行了钙激动剂BAY K 8644的替代测试。可卡因(0.625 - 10毫克/千克)使药物杠杆反应呈剂量相关增加,而BAY K 8644(0.25 - 2毫克/千克)和尼莫地平(0.2 - 0.8毫克/千克)主要引发生理盐水反应。与可卡因(2.5 - 10毫克/千克)联合使用时,尼莫地平在0.2和0.4毫克/千克剂量下将可卡因剂量 - 反应曲线向右移动;随着尼莫地平剂量增加(0.8和1.6毫克/千克),这种减弱并未增强。目前的结果表明,尼莫地平可能部分阻断可卡因的辨别性刺激特性,然而,这种降低既不显著也与剂量无关。因此,可以预期尼莫地平对人类主观可卡因状态的改变微乎其微。